There is currently no generic Jevtana (cabazitaxel) available, despite the fact that some of its patents have already expired. It is important to note that cabazitaxel is the "generic name" of Jevtana, not a generic version of it.
Can I Buy Generic Jevtana?Jevtana® (cabazitaxel) is a chemotherapy medication approved for the treatment of prostate cancer. It belongs to a group of medications known as taxanes. It is used when other types of prostate treatment have failed.
Jevtana is made by sanofi-aventis U.S., LLC. It is currently under the protection of a patent that prevents any generic versions from being manufactured in the United States.
When Will a Generic Version Be Available?
The first patents for Jevtana expired in July 2012 and November 2013, yet no generic versions of the drug are available. This strongly suggests that other, later-expiring patents are still protecting the drug from generic competition. The next patents are set to expire in March 2016. At this point, this is the earliest possible date that a generic version could become available.
However, circumstances could extend this exclusivity period. This could include such things as lawsuits or other patents for specific Jevtana uses. Once the patent expires, several companies will likely begin manufacturing generic Jevtana.
Is Cabazitaxel a Generic Jevtana?No -- cabazitaxel is the active ingredient in Jevtana, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.